Post-challenge hyperglycaemia is strongly associated with future macrovascular events and total mortality in

Harald Sourij1, Christoph H Saely, Fabian Schmid

  • 1Metabolism and Vascular Biology Research Group, Division of Endocrinology and Nuclear Medicine, Department of Internal Medicine, Medical University of Graz, Graz, Austria.

Insights

Post-challenge hyperglycaemia in coronary patients significantly increases the risk of future macrovascular events. An oral glucose tolerance test (oGTT) identifies these high-risk individuals with an unfavorable prognosis.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Syndrome

Background:

  • Post-challenge hyperglycaemia is prevalent in patients with coronary artery disease.
  • The association between post-challenge hyperglycaemia and macrovascular events in this population remains unclear.

Purpose of the Study:

  • To investigate the risk of future macrovascular events in coronary patients with post-challenge hyperglycaemia.

Main Methods:

  • 1040 patients undergoing coronary angiography were enrolled.
  • Oral glucose tolerance tests (oGTT) were performed in patients without pre-existing diabetes.
  • Macrovascular events and mortality were prospectively recorded over a 3.8-year follow-up.

Main Results:

  • Patients with post-challenge hyperglycaemia (280) and conventional diabetes (366) had significantly higher macrovascular event rates than those with normal glucose tolerance (394).
  • Adjusted hazard ratios for macrovascular events were 1.46 for post-challenge hyperglycaemia and 1.73 for conventional diabetes.
  • Post-challenge hyperglycaemia indicates a particularly unfavorable prognosis in stable coronary artery disease patients.

Conclusions:

  • Post-challenge hyperglycaemia is linked to increased future macrovascular events in patients evaluated for coronary artery disease.
  • oGTTs identify high-risk individuals with poor prognosis in this population.
Abstract

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...